RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response. Issue 9 (30th May 2022) - Kallieri, Maria; Zervas, Eleftherios; Fouka, Evangelia; Porpodis, Konstantinos; Mitrova, Marija Hadji; Tzortzaki, Eleni; Makris, Michael; Ntakoula, Maria; Papaioannou, Andriana I.; Lyberopoulos, Panagiotis; Dimakou, Katerina; Koukidou, Sofia; et al.